Fischer Medical Ventures Releases Preferential Issue Fund Monitoring Report
Fischer Medical Ventures Ltd 路 Others (Uncategorized) 路 14 Nov 2026, 9:17 pm
Fischer Medical Ventures Releases Preferential Issue Fund Monitoring Report Infomerics Valuation and Rating issued its Monitoring Agency Report for Fischer Medical Ventures for the quarter ended 30th Sep'26, confirming zero deviation from stated objects. Out of Rs. 358.45 crore net proceeds raised via preferential issue of equity shares and convertible warrants, the company utilized Rs. 332.56 crore through 30th Sep'26, including Rs. 51.63 crore deployed during the quarter. Growth objectives received full allocation of Rs. 268.84 crore, while Rs. 63.72 crore was utilized for general corporate purposes. The unutilized Rs. 25.89 crore remains parked in sweep-account fixed deposits.
Original exchange filing (PDF)
More announcements from Fischer Medical Ventures Ltd
- Financial results for the quarter and half year ended 30th Sept 2026 路 15 Nov 2026
- Outcome of Board Meeting held on 14th Nov 2026 for approval of Q2 financials 路 15 Nov 2026
- Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the unaudited standalone .... 路 14 Nov 2026
- Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company 路 27 Oct 2026
- Postal Ballot Notice & Scrutinizer 路 14 Oct 2026
